NewJour Home | NewJour: N | Search
[Prev] [Next]

National Cancer Institute. Journal.


-- Begin filtered message --

 From newjour-owner@ccat.sas.upenn.edu  Fri Sep 27 21:35:47 1996
 Received: (CCAT.SAS.UPENN.EDU [130.91.74.102]) by weber.ucsd.edu (8.7.5/8.7.3) with ESMTP id VAA05143 for <ss3@weber.ucsd.edu>; Fri, 27 Sep 1996 21:35:45 -0700 (PDT)
 Received: (from root@localhost) by ccat.sas.upenn.edu (8.7.6/8.7.3) id VAA44769 for newjour-outgoing; Fri, 27 Sep 1996 21:17:46 GMT
 Date: Fri, 27 Sep 1996 21:17:46 GMT
 From: owner-newjour@ccat.sas.upenn.edu
 Message-Id: <199609272117.VAA44769@ccat.sas.upenn.edu>
 Subject:  National Cancer Institute.  Journal.
 Sender: owner-newjour@ccat.sas.upenn.edu
 Precedence: bulk
 
 Date: Mon, 09 Sep 1996 20:52:03 -0400
 From: "Robert W. Hammond" <rhammond@mediquest.com>
 Organization: Medical Services Online LLC
 Subject: Re: Journals for New Jour
 
 
 National Cancer Institute.  Journal.
 
 http://medserv.com/jnci/toc/v88n17.htm
 (Link inactive 24 June 2004)

 http://jncicancerspectrum.oupjournals.org/
 (Link active 24 June 2004)
 
 The Journal of the National Cancer Institute is part of the Oncology
 Online.  Membership is presently open to physicians and Ph.D. researchers
 based in the United States. Similar services are under development for
 international member candidates. U.S.  Physicians who have a DEA number
 may register online now.  You will not be able to access this title
 without proper registration and password clearance. 
 
 Available issues in full text go back to Volume 88, no. 1, January 17,
 1996.  
 
 The National Cancer Institute does not guarantee that this electronic
 edition of the Journal of the National Cancer Institute (JNCI) is free of
 errors or omissions. Readers are advised to consult the print edition of
 the JNCI for the authoritative text.
 
 The Journal of the National Cancer Institute is a forum for news,
 information, and ideas related to cancer research, treatment, prevention,
 and control. Accordingly, all articles and items published in the Journal
 are signed and, unless otherwise stated, reflect the individual views of
 the authors and not official points of view held by the National Cancer
 Institute, any other component of the U.S.  government, or the
 organizations with which the authors are affiliated.  The mention of trade
 names, commercial products, or organizations does not imply endorsement by
 the National Cancer Institute or any other component of the U.S.
 government. Neither the National Cancer Institute nor any other component
 of the U.S. government assumes any responsibility for the completeness of
 the articles or other items or the accuracy of the conclusions reached
 therein. 
 
 The Journal of the National Cancer Institute (ISSN 0027-8874) is published
 semimonthly by the National Cancer Institute, National Institutes of
 Health, Public Health Service, U.S. Department of Health and Human
 Services, at 9030 Old Georgetown Rd., Bethesda, MD 20814.  
 
 Second class postage paid at Bethesda, MD, and additional mailing offices.
 All inquiries about subscriptions or depository library distribution
 should be directed to the National Cancer Institute (telephone: 
 1-800-624-7890 in the United States or 301-496-7600 outside the United
 States; fax:  301-231-6941).
 
 The Journal of the National Cancer Institute has been deemed by the
 Secretary of Health and Human Services to be necessary in the transaction
 of the public business required by law of this department.  Use of funds
 for printing this periodical has been approved by the Director of the
 Office of Management and Budget. All material published in the Journal is
 in the public domain; permission to reproduce any portion of its contents
 is, therefore, not necessary.  Questions about manuscript submission or
 other editorial matters may be addressed to the Journal Office, Rm. 209,
 9030 Old Georgetown Rd., Bethesda, MD 20814 (telephone: 301-496-6975; fax: 
 301-402-0212). Questions about placing public service announcements of
 employment openings, fellowship opportunities, and upcoming meetings may
 be addressed to the Announcements Editor in Rm. 217 at the same address. 
 (Note: Announcements for the News section should be sent to J. Paul Van
 Nevel, Bldg. 31, Rm.  10A29, Bethesda, MD 20892.) 
 

-- End of filtered message --


NewJour Home | NewJour: N | Search
[Prev] [Next]